Forever.AI: AI, Robotics, Quantum, Longevity, Cryonics & BCI
Subscribe
Sign in
Home
Archive
About
AI as a Stakeholder: What Every Pharma CEO Should Know About Communicating with AI
Communicating with AI today and in the future may require new levels of intensity, transparency, and communication mediums
Sep 23
•
Alex Zhavoronkov
19
1
GLP-1s: The world's first longevity drug?
The "DeepSeek Moment" in the longevity biotechnology we've all been waiting for transpired on August 29, 2025 at the 12th ARDD meeting in Copenhagen
Sep 9
•
Alex Zhavoronkov
40
2
August 2025
Beyond GLP-1: Is NLRP3 the Next Trillion Dollar Target?
This 24-year-old target demonstrates promise across multiple chronic diseases and has been prioritized by two AI-driven longevity companies. The quality…
Aug 12
•
Alex Zhavoronkov
30
2
Decoding Longevity: How AI is Ranking the Top Pharma Players
Have you ever wondered which pharmaceutical companies have extended human longevity in the past—and which ones will shape its future?
Aug 7
•
Alex Zhavoronkov
32
2
July 2025
Hacking Humanity: How technology can save your health and your life
New longevity book by Lara Lewington (BBC Journalist, television presenter)
Jul 10
•
Alex Zhavoronkov
13
3
June 2025
Super Agers - Eric Topol's New Longevity Book
I have a confession to make: I'm working on a new longevity book.
Jun 8
•
Alex Zhavoronkov
21
2
May 2025
23andMe and the Future of Human Genomic Data Privacy and Security
Over 15 million genomes with profile and metadata used, hacked, bankrupted, then sold for $256 Million. What lessons did we learn?
May 28
•
Alex Zhavoronkov
6
Does Taurine Supplementation Promote Cancer or Extend Lifespan? Or Both?
New paper in Nature uncovers scary facts that can be easily misinterpreted
May 15
•
Alex Zhavoronkov
12
2
Toward Pharmaceutical Superintelligence
Will we ever see perfect safe real-time cures on demand and where are we today?
May 12
•
Alex Zhavoronkov
14
This site requires JavaScript to run correctly. Please
turn on JavaScript
or unblock scripts